Bicara Therapeutics Inc. Common Stock

General ticker "BCAX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $913.6M (TTM average)

Bicara Therapeutics Inc. Common Stock follows the US Stock Market performance with the rate: 51.6%.

Estimated limits based on current volatility of 3.1%: low 28.79$, high 30.63$

Factors to consider:

  • Total employees count: 200000 as of 2024
  • Company does not operate outside US (retrieved using AI)
  • Top business risk factors: Limited operating history, Operational and conduct risks, Clinical trial failure, Regulatory and compliance, Capital raising
  • Current price 19.8% above estimated high
  • Earnings for 3 months up through Q1 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [11.77$, 24.21$]
  • 2026-12-31 to 2027-12-31 estimated range: [9.78$, 20.82$]

Similar symbols

Short-term BCAX quotes

Long-term BCAX plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $39.89MM $82.39MM $155.60MM
Operating Income $-39.89MM $-82.39MM $-155.60MM
Non-Operating Income $-12.09MM $14.58MM $17.87MM
R&D Expense $30.62MM $63.62MM $125.10MM
Income(Loss) $-51.98MM $-67.81MM $-137.73MM
Taxes $0.01MM $0.19MM $0.22MM
Net Income(Loss)* $-51.98MM $-68.00MM $-137.95MM
Stockholders Equity $-148.77MM $491.88MM $401.45MM
Assets $233.98MM $510.00MM $430.99MM
Operating Cash Flow $-45.63MM $-74.75MM $-106.83MM
Capital expenditure $0.59MM $0.07MM $0.28MM
Investing Cash Flow $-0.59MM $-0.01MM $-318.45MM
Financing Cash Flow $272.50MM $334.03MM $32.26MM
Earnings Per Share** $-1.00 $-1.25 $-2.52

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.